Locatim (previously Serinucoli)

RSS

Locatim, oral solution for neonatal calves less than 12 hours of age

Authorised
This medicine is authorised for use in the European Union.

Overview

Locatim is a veterinary medicine used to reduce death in newborn calves caused by enterotoxicosis due to the bacterium Escherichia coli during the first days of life. Enterotoxicosis is a disease caused by the release of toxins in the body, with the main symptom being diarrhoea.

Locatim contains the active substance bovine concentrated lactoserum containing specific immunoglobulins G against E. coli F5 (K99) adhesin.

This EPAR was last updated on 23/02/2021

Authorisation details

Product details
Name
Locatim (previously Serinucoli)
Agency product number
EMEA/V/C/000041
Active substance
Bovine concentrated lactoserum containing specific immunoglobulins G against E. coli F5 (K99) adhesin
International non-proprietary name (INN) or common name
Locatim, oral solution for neonatal calves less than 12 hours of age
Species
Calves, neonatal less than 12 hrs of age
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI02AT01
Publication details
Marketing-authorisation holder
Biokema Anstalt
Revision
13
Date of issue of marketing authorisation valid throughout the European Union
29/03/1999
Contact address
Pflugstrasse 12
Fürstentum
9490 Vaduz
Liechtenstein

Product information

09/12/2020 Locatim (previously Serinucoli) - EMEA/V/C/000041 - IAIN-0016

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Immunologicals for bovidae

Therapeutic indication

Reduction of mortality caused by enterotoxicosis associated with E. coli F5 (K99) adhesin during the first days of life as a supplement to colostrum from the dam.

Assessment history

How useful was this page?

Add your rating